People: Innophos Holdings Inc (IPHS.OQ)
Ms. Linda J. Myrick is an Independent Director of Innophos Holdings Inc., since October 2006. Ms. Myrick is Biomarkets Program Director & Med-Tech Program Director, R&D, American Air Liquide. Ms. Myrick is responsible for global R&D programs for Food, Pharmaceuticals, Water and Waste Treatment, Biofuels, and Medical Technologies based in Newark, Delaware. She relocated from the Centre de Recherche Claude-Delorme in Paris, France where she spent 3 1/2 years as the R&D Group Manager for Medical Gases for Air Liquide Santé International. She began working for Air Liquide with the acquisition of Scott Specialty Gases, Inc. in 2007 where she was General Manager for Scott Medical Products in Philadelphia, Pennsylvania. Before joining Scott in 2004, she held executive management positions with Rhodia, Inc. from 2001 including Vice President & General Manager—North America, Home, Personal Care & Industrial Ingredients, and Vice President & General Manager—North America, Specialty Phosphates. Prior to joining Rhodia, Ms. Myrick held positions in marketing, strategic planning and general management with FMC Corporation. Since 2006, she is an independent Director for Innophos, Inc., a publicly traded specialty phosphates and minerals corporation, and previously served as an independent Director for Berwind Pharmaceutical Services, Inc., a company providing pharmaceutical coatings and excipients. Ms. Myrick earned a B.S. in Chemical Engineering from the University of Delaware, where she is a member of the Alumni Association and the Chemical Engineering Advisory Board. She has an M.B.A. from the Wharton Graduate School of the University of Pennsylvania.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|